Bieganowski, Thomas http://orcid.org/0000-0002-1566-7962
Buchalter, Daniel B.
Singh, Vivek
Mercuri, John J.
Aggarwal, Vinay K.
Rozell, Joshua C.
Schwarzkopf, Ran
Article History
Received: 30 December 2021
Accepted: 21 May 2022
First Online: 20 June 2022
Declarations
:
: The present study was exempt from institutional review board (IRB) approval. Not applicable.
: Not applicable.
: TB, DB, VS, VA, and JR have nothing to disclose. JM is a paid consultant for Medacta. RS is a paid consultant for Intellijoint and Smith&Nephew; holds IP royalties in Smith&Nephew; and holds stock options in Gauss Surgical, Intellijoint, and PSI.